Literature DB >> 30319070

Histology of Nivolumab-Induced Thyroiditis.

Christina Neppl1, Reto M Kaderli2, Roman Trepp3, Anja M Schmitt1,3, Martin D Berger4, Marc Wehrli4, Christian A Seiler2, Rupert Langer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30319070     DOI： 10.1089/thy.2018.0418

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  8 in total

Review 1.  Organ-specific Adverse Events of Immune Checkpoint Inhibitor Therapy, with Special Reference to Endocrinopathies.

Authors:  Annu Susan George; Cornelius J Fernandez; Dilip Eapen; Joseph M Pappachan
Journal:  touchREV Endocrinol       Date:  2021-04-28

2.  Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.

Authors:  Norio Okada; Shintaro Iwama; Takayuki Okuji; Tomoko Kobayashi; Yoshinori Yasuda; Eri Wada; Takeshi Onoue; Motomitsu Goto; Mariko Sugiyama; Taku Tsunekawa; Hiroshi Takagi; Daisuke Hagiwara; Yoshihiro Ito; Hidetaka Suga; Ryoichi Banno; Tetsunari Hase; Masahiro Morise; Mitsuro Kanda; Kenji Yokota; Naozumi Hashimoto; Masahiko Ando; Yasushi Fujimoto; Masato Nagino; Yasuhiro Kodera; Mitsuhiro Fujishiro; Hideharu Hibi; Michihiko Sone; Hitoshi Kiyoi; Momokazu Gotoh; Yuichi Ando; Masashi Akiyama; Yoshinori Hasegawa; Hiroshi Arima
Journal:  Br J Cancer       Date:  2020-02-03       Impact factor: 7.640

Review 3.  Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review.

Authors:  Maria Stelmachowska-Banaś; Izabella Czajka-Oraniec
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335

4.  Endocrine immune-related adverse events: a double-edged sword?

Authors:  Michelle Rengarajan; Justin F Gainor
Journal:  Transl Lung Cancer Res       Date:  2021-01

Review 5.  Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors.

Authors:  Shintaro Iwama; Tomoko Kobayashi; Hiroshi Arima
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-27

6.  Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients.

Authors:  Han-Sang Baek; Chaiho Jeong; Kabsoo Shin; Jaejun Lee; Heysun Suh; Dong-Jun Lim; Moo Il Kang; Jeonghoon Ha
Journal:  BMC Endocr Disord       Date:  2022-04-04       Impact factor: 2.763

Review 7.  Thyroid-related adverse events induced by immune checkpoint inhibitors.

Authors:  Alexandra Chera; Andreea Lucia Stancu; Octavian Bucur
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

8.  Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report.

Authors:  Jörg Jabkowski; Almute Loidl; Barbara Auinger; Helmut Kehrer; Norbert Sepp; Robert Pichler
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.